The finding, from a University of Michigan study, could help inform the treatment of the roughly 10 million people worldwide who fall ill with tuberculosis each year, researchers said.
Active tuberculosis is notoriously difficult to treat, and the spread of antibiotic-resistant TB is increasing.
Current drug regimens start with four different antibiotics for the first two months, dropping to two antibiotics for four more months of treatment.
Experiments with animals are expensive and time-consuming, and present ethical dilemmas, so the team is developing a reliable computer model of tuberculosis that can test many drug combinations and treatment regimens quickly.
Also Read
Their study demonstrates how treatments with the standard antibiotics isoniazid and rifampin fare when taken according to different regimens approved by the US Centre for Disease Control. These include larger doses a few times per week and smaller daily doses.
The computer simulations showed that daily treatment with both antibiotics is the best way to go, but even then, the drugs have a hard time killing off all of the TB bacteria.
"The drugs actually have to penetrate into the core of this granuloma," said Denise Kirschner, U-M professor of microbiology and immunology.
Kirschner said the bacteria can protect themselves further by going into a passive state, in which they stop trying to reproduce.
'"If it's just sitting there, the drug is not going to have as strong an effect on it, which is why you have to treat for six months. You need to catch those bacteria in the few moments when they divide," she said.
They also explored what drug properties to target to make isoniazid and rifampin more effective.
For instance, they found that if the cells in the body absorbed about 20 per cent less isoniazid, allowing the drug more time to kill TB bacteria, it could drop the treatment failure rate from 1 per cent to nearly 0 per cent.
tuberculosis as "Ebola with wings" while urging Prime Minister Narendra Modi to "forget bullet trains" and provide tools, drugs and labs to fight the disease.
Udwadia said Ebola gets all the attention and during the last outbreak, which lasted 15 months, 11,000 people died and it was widely publicised.
"In the same time window, TB killed 2.1 million people. TB is Ebola with wings. In India, TB exists on an epic scale. India houses the most TB patients in the world. One Indian dies of TB every minute. TB costs this country 24 billion dollars every year.
He said the disease is not a glamorous one but kills slowly and agonisingly by ravaging the lungs and is a "perfect assassin".
The new study from the Centre for Disease Dynamics, Economics and Policy (CDDEP) said an urban tuberculosis case infects more individuals per year while a similar case in rural area remains infectious for longer period, new research has found.
According to reports, the disease is estimated to kill 4.8 lakh Indians every year although it is now believed that these numbers are underrepresented and the mortality could be 5 lakh a year.